Cocaine

This classification denotes a cns stimulant with the molecular formula C17H21NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I5Y540LHVR, chemically known as 8-azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1r-(exo,exo))- but generally known as cocaine, which bears US NIH Compound Identifier 5760. European Medicines Agency schedules Cocaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13416MIG. World Health Organization schedules cocaine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule cocaine under HS 29399110 and SITC 54149. As of Q4 2014, COCAINE remains the US FDA Preferred Term for this commodity. Cocaine bears US NLM identifiers UMLS ID C0009170 and NCI Concept Code C80153. SMILES: CN1C2CCC1C(C(C2)OC(=O)C3=CC=CC=C3)C(=O)OC.